{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:23:21Z","timestamp":1792700601345,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900795"],"award-info":[{"award-number":["81900795"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40265-022-01816-x","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T08:02:45Z","timestamp":1670400165000},"page":"1717-1726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study"],"prefix":"10.1007","volume":"82","author":[{"given":"Qiang","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiow-Ing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-4205","authenticated-orcid":false,"given":"Sheng-Ming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"1816_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2741\/3950","volume":"17","author":"M Jin","year":"2012","unstructured":"Jin M, Yang F, Yang I, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 2012;17:656\u201369.","journal-title":"Front Biosci (Landmark Ed)."},{"key":"1816_CR2","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/rheumatology\/kez196","volume":"58","author":"G Singh","year":"2019","unstructured":"Singh G, Lingala B, Mithal A. Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology (Oxford). 2019;58:2177\u201380.","journal-title":"Rheumatology (Oxford)"},{"key":"1816_CR3","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/annrheumdis-2015-207919","volume":"75","author":"F Perez-Ruiz","year":"2016","unstructured":"Perez-Ruiz F, Sundy JS, Miner JN, et al. Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol. Ann Rheum Dis. 2016;75:1074\u201380.","journal-title":"Ann Rheum Dis"},{"key":"1816_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, et al. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74:661\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1816_CR5","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.clinthera.2016.05.007","volume":"38","author":"LJ Smolen","year":"2016","unstructured":"Smolen LJ, Gahn JC, Mitri G, et al. the budget impact of increased use of febuxostat in the management of gout: a US health plan managed care pharmacy and medical costs perspective. Clin Ther. 2016;38:1710\u201325.","journal-title":"Clin Ther"},{"key":"1816_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.2147\/TCRM.S3310","volume":"4","author":"M Hu","year":"2008","unstructured":"Hu M, Tomlinson B. Febuxostat in the management of hyperuricemia and chronic gout: a review. Ther Clin Risk Manag. 2008;4:1209\u201320.","journal-title":"Ther Clin Risk Manag"},{"key":"1816_CR7","doi-asserted-by":"crossref","unstructured":"Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64:1431\u201346.","DOI":"10.1002\/acr.21772"},{"key":"1816_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","volume":"378","author":"WB White","year":"2018","unstructured":"White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med. 2018;378:1200\u201310.","journal-title":"N Engl J Med"},{"issue":"1","key":"1816_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","volume":"84","author":"IA Ayta","year":"1999","unstructured":"Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 1999;84(1):50\u20136.","journal-title":"BJU Int"},{"key":"1816_CR10","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3899\/jrheum.141031","volume":"42","author":"N Schlesinger","year":"2015","unstructured":"Schlesinger N, Radvanski DC, Cheng JQ, et al. Erectile dysfunction is common among patients with gout. J Rheumatol. 2015;42:1893\u20137.","journal-title":"J Rheumatol"},{"key":"1816_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00296-019-04365-x","volume":"39","author":"L Luo","year":"2019","unstructured":"Luo L, Xiang Q, Deng Y, et al. Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis. Rheumatol Int. 2019;39:1527\u201335.","journal-title":"Rheumatol Int"},{"key":"1816_CR12","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-021-01719-w","volume":"45","author":"A Sansone","year":"2022","unstructured":"Sansone A, Reisman Y, Jannini EA. Relationship between hyperuricemia with deposition and sexual dysfunction in males and females. J Endocrinol Invest. 2022;45:691\u2013703.","journal-title":"J Endocrinol Invest"},{"key":"1816_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(12)60520-0","volume":"381","author":"R Shamloul","year":"2013","unstructured":"Shamloul R, Ghanem H. Erectile dysfunction. Lancet. 2013;381:153\u201365.","journal-title":"Lancet"},{"key":"1816_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2008.05.022","volume":"202","author":"AC Gagliardi","year":"2009","unstructured":"Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis. 2009;202:11\u20137.","journal-title":"Atherosclerosis"},{"key":"1816_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jjcc.2012.01.013","volume":"59","author":"P Puddu","year":"2012","unstructured":"Puddu P, Puddu GM, Cravero E, et al. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol. 2012;59:235\u201342.","journal-title":"J Cardiol"},{"key":"1816_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","volume":"278","author":"T Maruhashi","year":"2018","unstructured":"Maruhashi T, Hisatome I, Kihara Y, et al. Hyperuricemia and endothelial function: from molecular background to clinical perspectives. Atherosclerosis. 2018;278:226\u201331.","journal-title":"Atherosclerosis"},{"key":"1816_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3899\/jrheum.170444","volume":"45","author":"N Schlesinger","year":"2018","unstructured":"Schlesinger N, Lu N, Choi HK. Gout and the risk of incident erectile dysfunction: a body mass index-matched population-based study. J Rheumatol. 2018;45:1192\u20137.","journal-title":"J Rheumatol"},{"key":"1816_CR18","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3899\/jrheum.141105","volume":"42","author":"YF Chen","year":"2015","unstructured":"Chen YF, Lin HH, Lu CC, et al. Gout and a subsequent increased risk of erectile dysfunction in men aged 64 and under: a nationwide cohort study in Taiwan. J Rheumatol. 2015;42:1898\u2013905.","journal-title":"J Rheumatol"},{"issue":"13","key":"1816_CR19","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1111\/j.1742-4658.2008.06489.x","volume":"275","author":"T Nishino","year":"2008","unstructured":"Nishino T, Okamoto K, Eger BT, et al. Mammalian xanthine oxidoreductase\u2014mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 2008;275(13):3278\u201389.","journal-title":"FEBS J"},{"issue":"3","key":"1816_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11357-997-0012-2","volume":"20","author":"HY Chung","year":"1997","unstructured":"Chung HY, Baek BS, Song SH, et al. Xanthine dehydrogenase\/xanthine oxidase and oxidative stress. Age (Omaha). 1997;20(3):127\u201340.","journal-title":"Age (Omaha)."},{"key":"1816_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.ijir.3901523","volume":"19","author":"JY Jeremy","year":"2007","unstructured":"Jeremy JY, Jones RA, Koupparis AJ, et al. Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase. Int J Impot Res. 2007;19:265\u201380.","journal-title":"Int J Impot Res"},{"key":"1816_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003095","volume":"17","author":"A Tanaka","year":"2020","unstructured":"Tanaka A, Taguchi I, Teragawa H, et al. Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: a randomized, controlled trial. PLoS Med. 2020;17: e1003095.","journal-title":"PLoS Med"},{"issue":"6","key":"1816_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/art.41247","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879\u201395.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"1816_CR24","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/rheumatology\/kex150","volume":"56","author":"M Hui","year":"2017","unstructured":"Hui M, Carr A, Cameron S, et al. The British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2017;56(7):1056\u20139.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-022-01816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-022-01816-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-022-01816-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:33:21Z","timestamp":1679880801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-022-01816-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1007\/s40265-022-01816-x","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"20 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article was supported by funding from NSFC 81900795.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The TriNetX platform is compliant with the Health Insurance Portability and Accountability Act (HIPAA) and the General Data Protection Regulation (GDPR). The Western Institutional Review Board (WIRB) has granted a waiver to TriNetX because it contains only aggregated counts and statistical summaries of anonymized information. The use of TriNetX for the present study was approved by the Institutional Review Board of Chung Shan Medical University Hospital (CSMUH No: CS2-21176).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the listed authors have read and approved the final manuscript and agreed to publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data relevant to the study are included in the article.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials (data sharing statement)"}},{"value":".","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}